<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02461498</url>
  </required_header>
  <id_info>
    <org_study_id>PB-PG-0808-17148</org_study_id>
    <nct_id>NCT02461498</nct_id>
  </id_info>
  <brief_title>The AHEAD Study: Monitoring Anticoagulated Patients Who Suffer Head Injury</brief_title>
  <official_title>The AHEAD Study: Monitoring Anticoagulated Patients Who Suffer Head Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sheffield</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute for Health Research, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sheffield</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Existing practice in emergency departments (ED) in the United Kingdom (UK) for managing
      patients taking warfarin after a blunt head injury is variable with little research that
      supports the most appropriate way to manage these patients. The investigators aimed to
      undertake research in order to understand the range and frequency of outcomes following head
      injury in this group of patients and to develop robust clinical guidance for how they should
      be optimally managed in the future.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective observational study aims to enrol patients taking warfarin that attend
      participating ED's (up to 33) in England and Scotland after blunt head injury. Over an
      18-month period from Oct 2011, ED attendance data will be collected from each ED as well as
      information from patient questionnaires about the care the patient received and the status of
      their health 6-10 weeks after the injury. Patients who died due to their head injury,
      experienced surgery due to their injury, had a change identified on a CT scan or re-attended
      the ED with a clear head injury complication are defined as experiencing a poor outcome.
      Information such as the patients' conscious state (GCS), level of clotting in their blood
      (INR) and symptoms will be investigated as predictors of a poor outcome. A mathematical model
      will be used to estimate the most cost-effective strategy assuming published National
      Institute for Health and Care Excellence (NICE) thresholds for cost per quality adjusted life
      year (QALY).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of head injury complication in study cohort</measure>
    <time_frame>18 months</time_frame>
    <description>Head injury complications defined as death or neurosurgery resulting from the initial injury, a clinically-significant CT scan finding or re-attendance to the ED with a significant head injury-related complication up to 10 weeks after the original attendance.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of ongoing symptoms relating to the head injury</measure>
    <time_frame>18 months</time_frame>
    <description>Impaired activities of daily living (assessed by the EQ5D)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of ongoing symptoms relating to the head injury</measure>
    <time_frame>18 months</time_frame>
    <description>Headache symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of ongoing symptoms relating to the head injury</measure>
    <time_frame>18 months</time_frame>
    <description>Impaired cognitive function (assessed by the Glasgow Outcome Scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identification of early predictors of adverse clinical outcome</measure>
    <time_frame>18 months</time_frame>
    <description>Including clinical features and initial investigations which may be useful as a diagnostic tool.</description>
  </secondary_outcome>
  <enrollment type="Actual">3556</enrollment>
  <condition>Craniocerebral Trauma</condition>
  <condition>Head Injuries, Closed</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adults who attend participating emergency departments (ED) with a head injury and also
        prescribed warfarin
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  16 years or older

          -  Blunt head trauma above the neck within 24 hours of ED attendance

          -  Prescribed warfarin

        Exclusion Criteria:

          -  Penetrating injuries to the head, for example knife wound.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suzanne Mason, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sheffield</affiliation>
  </overall_official>
  <reference>
    <citation>Saab M, Gray A, Hodgkinson D, Irfan M. Warfarin and the apparent minor head injury. J Accid Emerg Med. 1996 May;13(3):208-9.</citation>
    <PMID>8733663</PMID>
  </reference>
  <reference>
    <citation>Stiell IG, Wells GA, Vandemheen K, Clement C, Lesiuk H, Laupacis A, McKnight RD, Verbeek R, Brison R, Cass D, Eisenhauer ME, Greenberg G, Worthington J. The Canadian CT Head Rule for patients with minor head injury. Lancet. 2001 May 5;357(9266):1391-6.</citation>
    <PMID>11356436</PMID>
  </reference>
  <reference>
    <citation>Haydel MJ, Preston CA, Mills TJ, Luber S, Blaudeau E, DeBlieux PM. Indications for computed tomography in patients with minor head injury. N Engl J Med. 2000 Jul 13;343(2):100-5.</citation>
    <PMID>10891517</PMID>
  </reference>
  <reference>
    <citation>Mower WR, Hoffman JR, Herbert M, Wolfson AB, Pollack CV Jr, Zucker MI; NEXUS II Investigators. National Emergency X-Radiography Utilization Study. Developing a clinical decision instrument to rule out intracranial injuries in patients with minor head trauma: methodology of the NEXUS II investigation. Ann Emerg Med. 2002 Nov;40(5):505-14.</citation>
    <PMID>12399794</PMID>
  </reference>
  <reference>
    <citation>Volans AP. The risks of minor head injury in the warfarinised patient. J Accid Emerg Med. 1998 May;15(3):159-61.</citation>
    <PMID>9639176</PMID>
  </reference>
  <reference>
    <citation>Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke. 1995 Aug;26(8):1471-7. Review.</citation>
    <PMID>7631356</PMID>
  </reference>
  <reference>
    <citation>Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994 Jun 1;120(11):897-902.</citation>
    <PMID>8172435</PMID>
  </reference>
  <reference>
    <citation>Ferrera PC, Bartfield JM. Outcomes of anticoagulated trauma patients. Am J Emerg Med. 1999 Mar;17(2):154-6.</citation>
    <PMID>10102316</PMID>
  </reference>
  <reference>
    <citation>Mathiesen T, Benediktsdottir K, Johnsson H, Lindqvist M, von Holst H. Intracranial traumatic and non-traumatic haemorrhagic complications of warfarin treatment. Acta Neurol Scand. 1995 Mar;91(3):208-14.</citation>
    <PMID>7793238</PMID>
  </reference>
  <reference>
    <citation>National Collaborating Centre for Acute Care (UK). Head Injury: Triage, Assessment, Investigation and Early Management of Head Injury in Infants, Children and Adults. London: National Collaborating Centre for Acute Care (UK); 2007 Sep.</citation>
    <PMID>21563330</PMID>
  </reference>
  <reference>
    <citation>Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998 Aug;15(8):573-85.</citation>
    <PMID>9726257</PMID>
  </reference>
  <reference>
    <citation>EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208.</citation>
    <PMID>10109801</PMID>
  </reference>
  <reference>
    <citation>Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med. 1993 Sep;95(3):315-28. Review.</citation>
    <PMID>8368229</PMID>
  </reference>
  <reference>
    <citation>Fortuna GR, Mueller EW, James LE, Shutter LA, Butler KL. The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury. Surgery. 2008 Oct;144(4):598-603; discussion 603-5. doi: 10.1016/j.surg.2008.06.009. Epub 2008 Aug 29.</citation>
    <PMID>18847644</PMID>
  </reference>
  <reference>
    <citation>Li J, Brown J, Levine M. Mild head injury, anticoagulants, and risk of intracranial injury. Lancet. 2001 Mar 10;357(9258):771-2.</citation>
    <PMID>11253975</PMID>
  </reference>
  <reference>
    <citation>Gittleman AM, Ortiz AO, Keating DP, Katz DS. Indications for CT in patients receiving anticoagulation after head trauma. AJNR Am J Neuroradiol. 2005 Mar;26(3):603-6.</citation>
    <PMID>15760873</PMID>
  </reference>
  <reference>
    <citation>Lavoie A, Ratte S, Clas D, Demers J, Moore L, Martin M, Bergeron E. Preinjury warfarin use among elderly patients with closed head injuries in a trauma center. J Trauma. 2004 Apr;56(4):802-7.</citation>
    <PMID>15187746</PMID>
  </reference>
  <reference>
    <citation>Fabbri A, Vandelli A, Servadei F, Marchesini G. Coagulopathy and NICE recommendations for patients with mild head injury. J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1787-8.</citation>
    <PMID>15548511</PMID>
  </reference>
  <reference>
    <citation>Teasdale G, Murray G, Parker L, Jennett B. Adding up the Glasgow Coma Score. Acta Neurochir Suppl (Wien). 1979;28(1):13-6.</citation>
    <PMID>290137</PMID>
  </reference>
  <reference>
    <citation>Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 2001 Dec;10(8):779-87.</citation>
    <PMID>11747057</PMID>
  </reference>
  <reference>
    <citation>Felli JC, Hazen GB. Sensitivity analysis and the expected value of perfect information. Med Decis Making. 1998 Jan-Mar;18(1):95-109. Erratum in: Med Decis Making. 2003 Jan-Feb;23(1):97.. Med Decis Making 2001 May-Jun;21(3):254.</citation>
    <PMID>9456214</PMID>
  </reference>
  <reference>
    <citation>Ades AE, Lu G, Claxton K. Expected value of sample information calculations in medical decision modeling. Med Decis Making. 2004 Mar-Apr;24(2):207-27.</citation>
    <PMID>15090106</PMID>
  </reference>
  <reference>
    <citation>Wilson JT, Edwards P, Fiddes H, Stewart E, Teasdale GM. Reliability of postal questionnaires for the Glasgow Outcome Scale. J Neurotrauma. 2002 Sep;19(9):999-1005.</citation>
    <PMID>12482113</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2015</study_first_submitted>
  <study_first_submitted_qc>May 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2015</study_first_posted>
  <last_update_submitted>May 29, 2015</last_update_submitted>
  <last_update_submitted_qc>May 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sheffield</investigator_affiliation>
    <investigator_full_name>Professor Suzanne Mason</investigator_full_name>
    <investigator_title>Professor of Emergency Medicine</investigator_title>
  </responsible_party>
  <keyword>Warfarin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Craniocerebral Trauma</mesh_term>
    <mesh_term>Head Injuries, Closed</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

